DIA Europe 2025

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

Spotlight session Tuesday, 18th March 2025 12:15-13:00, Location (Hall) – Sydney

Topic: How does a harmonized, unified, and integrated platform enhance pharmacovigilance processes, and what are the key benefits of consolidating multiple systems into a single solution?

Presenter: Raj More, CEO and Chief Architect, RxLogix Corporation

Learn more about how adopting a harmonized, unified, and integrated PV Platform consolidates various systems into a cohesive solution with GenAI end-to-end, leading to increased efficiency, cost savings, scalability, enhanced security, and improved collaboration.

• Streamlined Operations
• Enhanced Data Transparency and Accessibility
• Efficiency and Productivity
• Improved Data Quality and Accessibility
• Regulatory Compliance and Reporting
• Cost Reduction
• Scalability and Flexibility
• AI and Automation- Minimal Manual Work

Innovation Hub Wednesday 19th March 2025 09:50 – 10:15

Innovating Data Analytics for Drug Safety: Harnessing AI, Automation, and Advanced Insights

Presenter: Raj More, CEO and Chief Architect, RxLogix Corporation

In the rapidly evolving world of pharmacovigilance, the demand for cutting-edge data analytics has never been greater. For years, RxLogix has been at the forefront of innovation in Pharmacovigilance Data Analytics and Insights, consistently replacing legacy reporting solutions across pharmaceutical companies of all sizes.

This session will explore how the RxLogix platform has digitally transformed PV data analytics on a global scale, setting a new industry benchmark for innovation.

We’ll also delve into how our Next-Gen analytics platform leverages machine learning, real-world evidence, and predictive modeling to enhance adverse event detection, optimize decision-making, and provide significant efficiency gains in end-to-end processing & management of PV documents.

Join us to discover how data-driven innovation is shaping the future of drug safety, improving patient outcomes, and redefining industry standards.